BIO-Europe, one of the world’s leading partnering events for the biotech and pharmaceutical industry, returns to Cologne on 9–11 November 2026. Presented as “the epicenter of biotech”, the event brings together biopharma leaders, investors, start-ups and partners from across the globe to build collaborations and move innovation towards impact.
What to expect
With 5,800+ attendees from 3,200+ companies in more than 60 countries, BIO-Europe is a key meeting point for anyone looking to grow partnerships in life sciences. Over three days, participants can take part in:
- One-to-one partnering meetings to explore licensing, collaboration and investment opportunities
- Company presentations showcasing innovative assets and technologies
- Panels and expert sessions on the trends shaping the biotech and pharma landscape
- An exhibition area where clusters, companies and service providers present their ecosystems
CEBR at BIO-Europe
Life science clusters play a key role at events like BIO-Europe, connecting their companies and start-ups with international partners and investors. This year, many CEBR members will be in Cologne, exhibiting or visiting.
To bring the network together, CEBR invites its members to an informal gathering and group photo at the Atlanpole Biotherapies booth (7-67) on Monday 9 November at 12:00. CEBR President Hickmah Tagaully and Board member Alexis [surname] will be there, together with Elodie Girardet from Atlanpole Biotherapies, to welcome you. Not a CEBR member but curious about our network? You’re very welcome to join us too!
